- Exchange: Stockholm
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Snapshot for Getinge AB (GETIB)
| Open: | 182.200 | Day's Range: | 181.300 - 185.700 | Volume: | 441,130 | Bid: | 184.600 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 182.200 | 52wk Range: | 132.500 - 196.500 | 1-Yr Rtn: | +10.29% | Ask: | 184.700 |
Stock Chart for GETIB
Key Statistics for GETIB
| Current P/E Ratio (ttm) | 17.3685 |
|---|---|
| Estimated P/E (12/2012) | 14.4796 |
| Earnings Per Share (SEK) (ttm) | 10.6284 |
| Est. EPS (SEK) (12/2012) | 12.7490 |
| Est. PEG Ratio | 1.1192 |
| Market Cap (M SEK) | 43,994.50 |
| Shares Outstanding (M) | 222.38 |
| Enterprise Value (M SEK) (ttm) | 59,504.50 |
| Enterprise Value/EBITDA (ttm) | 10.84 |
| Price/Book (mrq) | 2.9582 |
| Price/Sale (ttm) | 1.9615 |
| Dividend Indicated Gross Yield | 2.0314 |
| Next Earnings Announcement | 07/10/2012 |
More GETIB Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for GETIB
- Operating
- Investing
- Financing (M/SEK)
Company Profile & Key Executives for GETIB
Getinge AB develops, manufactures, and sells equipment and systems for sterilization and disinfection. The Company markets to the pharmaceutical industry, hospitals, dental clinics, and laboratories. Getinge produces in the United Kingdom, France, the United States, and Australia. The products are sold by subsidiaries, sales offices, and distributors worldwide.
| Carl BennetChairman | Johan MalmquistPresident/CEO |
| Ulf GrunanderChief Financial Officer | Niclas M OllsonPres:China/Gen Mgr:East Asia |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page